1312 — Kontafarma China Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$206.78m
- HK$457.60m
- HK$809.11m
- 27
- 78
- 18
- 33
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 122 | -0.297 | -0.326 | -118 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 123 | 188 | -54.1 | 121 | — |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -380 | -158 | -62 | -136 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 25.7 | 207 | 75.1 | -2.17 | — |
Capital Expenditures | -90.2 | -166 | -124 | -51.7 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 203 | -39.9 | 148 | 173 | — |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 112 | -206 | 23.2 | 122 | — |
Financing Cash Flow Items | 84.1 | -112 | -101 | -135 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -82.1 | 19.1 | -99.8 | -137 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 47.1 | 17.5 | 2.14 | -45.4 | — |